Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of vildagliptin 50 mg bid as
an add-on therapy to metformin in Japanese patients with T2DM. This study is being conducted
to support registration of the fixed-dose combination of vildagliptin and metformin for the
treatment of Type 2 diabetes mellitus (T2DM) in Japan.